Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, has postponed its planned Nasdaq cross-listing, citing adverse market conditions. The company had been seeking to raise $53 million through the offering, which would have provided the Australian-listed manufacturer with a US market listing under the ticker AMRO.
Company Background
Amaero develops and produces titanium and refractory metal powders designed for additive manufacturing applications. Its products are used in defense and aerospace 3D printing, positioning the company within advanced manufacturing markets serving high-performance applications.
The McDonald, Tennessee-based company was founded in 2013 and generated $12 million in revenue for the 12 months ended June 30, 2026. Amaero is already listed on the Australian Securities Exchange under the ticker 3DA.
IPO Details
Amaero had planned to raise $53 million by offering 7.5 million shares at an assumed price of $7.06 per share. The proposed price was based on the as-converted September 11 closing price of its shares on the Australian Securities Exchange.
The company planned to list on the Nasdaq under the symbol AMRO. Stifel and Baird were set to serve as joint bookrunners for the transaction.
Market Context & Opportunities
Amaero’s proposed US listing would have provided the company with access to Nasdaq investors while expanding its presence in the US public markets. Its focus on titanium and refractory metal powders for aerospace and defense 3D printing places the company within specialized advanced manufacturing markets.
However, the decision to postpone the offering highlights the influence of broader market conditions on smaller and specialized IPOs. The company specifically cited adverse market conditions as the reason for delaying the transaction.
Risks & Challenges
The postponement underscores the challenge of completing a public offering when market conditions are unfavorable. Amaero’s relatively small revenue base of $12 million for the latest 12-month period also means that investors would be evaluating the company’s ability to scale its specialized manufacturing operations and convert its technology and product portfolio into sustained commercial growth.
The company will also need to reassess the timing and structure of its proposed Nasdaq listing before returning to the US IPO market.
Closing Paragraph
Amaero’s decision to postpone its $53 million Nasdaq cross-listing reflects the difficulty of executing a smaller public-market transaction amid adverse conditions. While the company remains positioned around titanium and refractory metal powders for aerospace and defense applications, the timing of any future US offering will depend on market conditions and its ability to return to investors with a revised listing plan.